Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Case Reports
. 2017 Dec 19;4(1):50-52.
doi: 10.1016/j.jdcr.2017.09.024. eCollection 2018 Jan.

Cutaneous Polyarteritis Nodosa Resulting From a Paclitaxel-Eluting Balloon Angioplasty

Affiliations
Free PMC article
Case Reports

Cutaneous Polyarteritis Nodosa Resulting From a Paclitaxel-Eluting Balloon Angioplasty

Allison Montgomery et al. JAAD Case Rep. .
Free PMC article

Abstract

No abstract available

Keywords: IL, interleukin; angioplasty; cPAN, cutaneous polyarteritis nodosa; drug-eluting balloon; pANCA, perinuclear antineutrophil cytoplasmic antibodies; paclitaxel; polyarteritis nodosa.

Figures

Fig 1
Fig 1
Clinical image of anterior aspect of left leg.
Fig 2
Fig 2
Clinical image of medial aspect of left leg.
Fig 3
Fig 3
Histopathologic image at 10× magnification.
Fig 4
Fig 4
Histopathologic image at 40× magnification.

Similar articles

See all similar articles

References

    1. Micheletti R. Cutaneous polyarteritis nodosa. Ofori A, Curtis M (Ed.), UpToDate. 30 July 2017. http://www.uptodate.com/contents/cutaneous-polyarteritis-nodosa.
    1. Thomas S.D., McDonald R., Varcoe R. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon. J Vasc Surg. 2014;59:520–523. - PubMed
    1. Heilmann T., Richter C., Noack H. Drug release profiles of different drug-coated balloon platforms. Eur Cardiol. 2010;6(4):40–44.
    1. “Lutonix® 035 Drug Coated Balloon PTA Catheter.” Bard Peripheral Vascular. Bard, 2016. http://www.bardpv.com/. 26 July 2017.
    1. Otsuka F., Vorpahl M., Nakano M. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation. 2014;129(2):211–223. - PMC - PubMed

Publication types

LinkOut - more resources

Feedback